These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1465894)

  • 1. Donor heart preservation with three different solutions: donor heart function at more than 1 year after transplantation.
    Weyand M; Konertz W; Deiwick M; Hachenberg T; Scheld HH; Bernhard A
    Transplant Proc; 1992 Dec; 24(6):2665-6. PubMed ID: 1465894
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term function of Euro-Collins--preserved human cardiac allografts.
    Weyand M; Hermann G; Konertz W; Bernhard A; Scheld HH
    Transplant Proc; 1992 Oct; 24(5):2011-2. PubMed ID: 1412952
    [No Abstract]   [Full Text] [Related]  

  • 3. Temperature-dependent cardioprotection of exogenous substrates in long-term heart preservation with continuous perfusion: twenty-four-hour preservation of isolated rat heart with St. Thomas' Hospital solution containing glucose, insulin, and aspartate.
    Shimada Y; Yamamoto F; Yamamoto H; Oka T; Kawashima Y
    J Heart Lung Transplant; 1996 May; 15(5):485-95. PubMed ID: 8771504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrograde pulmonaryplegia for lung preservation in clinical transplantation: a new technique.
    Sarsam MA; Yonan NA; Deiraniya AK; Rahman AN
    J Heart Lung Transplant; 1993; 12(3):494-8. PubMed ID: 8329424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hypothermic storage of the mammalian heart for transplantation: a comparison of three cardioplegic solutions.
    Galiñanes M; Murashita T; Hearse DJ
    J Heart Lung Transplant; 1992; 11(4 Pt 1):624-35. PubMed ID: 1498125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor heart preservation--limitations of cardioplegia and warm ischemia.
    Wicomb WN; Hill DJ; Avery JG; Collins GM
    Transplantation; 1992 Apr; 53(4):947-9. PubMed ID: 1566365
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of blood-based and crystalloid cardiopneumoplegic solutions in heart and lung preservation for 24 hours: an ultrastructural morphometric study in dogs.
    Tédy G; Corbi P; Rabago G; Muneretto C; Pavie A; Chomette G; Cabrol C; Gandjbakhch I
    Transplant Proc; 1993 Jun; 25(3):2222-5. PubMed ID: 8516878
    [No Abstract]   [Full Text] [Related]  

  • 8. Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.
    Flameng W; De Meyere R; Daenen W; Sergeant P; Ngalikpima V; Geboers J; Suy R; Stalpaert G
    J Thorac Cardiovasc Surg; 1986 May; 91(5):723-31. PubMed ID: 3517508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evaluation of Bretschneider's solution for myocardial preservation in cardiac transplantation.
    Sueda T; Maeda Y; Hamanaka Y; Ishihara H; Matsuura Y; Kajihara H
    Hiroshima J Med Sci; 1987 Sep; 36(3):309-13. PubMed ID: 3121539
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of currently used methods for lung preservation with prostacyclin and University of Wisconsin solution.
    Hirt SW; Wahlers T; Jurmann M; Fieguth HG; Dammenhayn L; Haverich A
    J Heart Lung Transplant; 1992; 11(4 Pt 1):656-64. PubMed ID: 1498128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of intracellular solutions for donor heart preservation.
    Hendry PJ; Labow RS; Keon WJ
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of University of Wisconsin and Stanford solution for heart preservation: coronary flow reserve in the posttransplant myocardium.
    Moriyama Y; Maruyama T; Pennington DG; Seki T; Steigman CK; Swartz MT
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1601-3. PubMed ID: 8442206
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of preservation solution on early function and graft survival in cadaveric renal transplantation.
    Albrecht K; Zühlke M; Kruschke A; Eigler FW
    Transplant Proc; 1993 Aug; 25(4):2561-2. PubMed ID: 8356669
    [No Abstract]   [Full Text] [Related]  

  • 14. Three solutions for preservation of the rabbit heart at 0 degree C. A comparison with phosphorus-31 nuclear magnetic resonance spectroscopy.
    English TA; Foreman J; Gadian DG; Pegg DE; Wheeldon D; Williams SR
    J Thorac Cardiovasc Surg; 1988 Jul; 96(1):54-61. PubMed ID: 3133527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior qualities of University of Wisconsin solution for ex vivo preservation of the pig heart.
    Mankad PS; Severs NJ; Lachno DR; Rothery S; Yacoub MH
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):229-40. PubMed ID: 1495284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved heart preservation with UW preservation solution.
    Swanson DK; Pasaoglu I; Berkoff HA; Southard JA; Hegge JO
    J Heart Transplant; 1988; 7(6):456-67. PubMed ID: 3145337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ specificity of pancreas preservation compared with kidney and heart preservation.
    Kin S; Gu K; Nagami H; Saitoh Y; Nakayama K; Tamura K; Stephanian E; Sutherland D
    Transplant Proc; 1996 Feb; 28(1):335-6. PubMed ID: 8644248
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of the immature myocardium. An experimental evaluation of topical cooling, single-dose, and multiple-dose administration of St. Thomas' Hospital cardioplegic solution.
    Magovern JA; Pae WE; Waldhausen JA
    J Thorac Cardiovasc Surg; 1988 Sep; 96(3):408-13. PubMed ID: 3411985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. University of Wisconsin solution versus Stanford cardioplegic solution and the development of cardiac allograft vasculopathy.
    Drinkwater DC; Rudis E; Laks H; Ziv E; Marino J; Stein D; Ardehali A; Aharon A; Moriguchi J; Kobashigawa J
    J Heart Lung Transplant; 1995; 14(5):891-6. PubMed ID: 8800725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.